Search research articles
Contact Us
Filters
Showing results (101-110 of 120) with videos related to
Page
of 12
Sort By:
Nature Communications
|
February 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostaining
Fan Wu, Shuyuan Zheng, Yani Chen, et al.
Nature Communications
|
June 20, 2023
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
Thatcher Heumann, Carol Judkins, Keyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Nature Cancer
|
February 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova, et al.
Nature Cancer
|
November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity
Won Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Cancer Immunology Research
|
August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironment
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
The Journal of Clinical Investigation
|
December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
Mark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Cell Systems
|
April 20, 2023
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces
Atul Deshpande, Melanie Loth, Dimitrios N Sidiropoulos, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 120) with videos related to
Sort By:
Page
of 12
Nature Communications
|
February 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostaining
Fan Wu, Shuyuan Zheng, Yani Chen, et al.
Nature Communications
|
June 20, 2023
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
Thatcher Heumann, Carol Judkins, Keyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Nature Cancer
|
February 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova, et al.
Nature Cancer
|
November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity
Won Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Cancer Immunology Research
|
August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironment
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
The Journal of Clinical Investigation
|
December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
Mark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders
Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Cell Systems
|
April 20, 2023
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces
Atul Deshpande, Melanie Loth, Dimitrios N Sidiropoulos, et al.
Page
of 12